HIV gp120 interactions with coreceptors: Insights from studies with CCR5-based peptides

被引:0
|
作者
Berger, Edward A.
Alkhatib, Ghalib
机构
[1] NIAID, NIH, Viral Dis Lab, Bethesda, MD 20892 USA
[2] Indiana Univ, Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA
关键词
HIV; AIDS; coreceptor; CCR5; CXCR4; chemokine receptor; CD4; GPCR; peptides; fusion; entry;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Human immunodeficiency virus enters cells by a direct fusion mechanism triggered by sequential binding of the gp120 subunit of the envelope glycoprotein, first to CD4, then to the coreceptor CCR5 or CXCR4. The coreceptors are chemokine receptors, members of the superfamily of G protein-coupled receptors that are characterized by 7 transmembrane domains. gp120 is presumed to interact with the extracellular portion, which consists of the N-terminal segment and three extracellular loops. Synthetic peptides based on these regions have proven to be valuable probes for elucidating the molecular details of the complex gp120-coreceptor interactions.
引用
收藏
页码:403 / 407
页数:5
相关论文
共 50 条
  • [31] Blockade of chemokine-induced signalling inhibits CCR5-dependent HIV infection in vitro without blocking gp120/CCR5 interaction
    David J Grainger
    Andrew ML Lever
    [J]. Retrovirology, 2
  • [32] Novel Peptides Based on HIV-1 gp120 Sequence with Homology to Chemokines Inhibit HIV Infection in Cell Culture
    Chertov, Oleg
    Zhang, Ning
    Chen, Xin
    Oppenheim, Joost J.
    Lubkowski, Jacek
    McGrath, Connor
    Sowder, Raymond C., II
    Crise, Bruce J.
    Malyguine, Anatoli
    Kutzler, Michele A.
    Steele, Amber D.
    Henderson, Earl E.
    Rogers, Thomas J.
    [J]. PLOS ONE, 2011, 6 (01):
  • [33] SYNTHETIC PEPTIDES FROM A CONSERVED REGION OF GP120 INDUCE BROADLY REACTIVE ANTI-HIV RESPONSES
    MORROW, WJW
    WILLIAMS, WM
    WHALLEY, AS
    RYSKAMP, T
    NEWMAN, R
    KANG, CY
    CHAMAT, S
    KOHLER, H
    KIEBEREMMONS, T
    [J]. IMMUNOLOGY, 1992, 75 (04) : 557 - 564
  • [34] EFFICIENT PURIFICATION AND RIGOROUS CHARACTERIZATION OF A RECOMBINANT GP120 FOR HIV VACCINE STUDIES
    JONES, DH
    MCBRIDE, BW
    ROFF, MA
    FARRAR, GH
    [J]. VACCINE, 1995, 13 (11) : 991 - 999
  • [35] Polymorphism characteristics of HIV-1 gp120 and 5 hypervariable regions
    Yao, Neng
    Zhang, Chunxia
    Liu, Qi
    Liu, Jun
    Zhang, Chiyu
    [J]. TURKISH JOURNAL OF MEDICAL SCIENCES, 2015, 45 (01) : 47 - 54
  • [36] CD4-independent binding of SIV gp120 to rhesus CCR5
    Martin, KA
    Wyatt, R
    Farzan, M
    Choe, H
    Marcon, L
    Desjardins, E
    Robinson, J
    Sodroski, J
    Gerard, C
    Gerard, NP
    [J]. SCIENCE, 1997, 278 (5342) : 1470 - 1473
  • [37] Role of the HIV gp120 conserved domain 5 in processing and viral entry
    Sen, Jayita
    Jacobs, Amy
    Caffrey, Michael
    [J]. BIOCHEMISTRY, 2008, 47 (30) : 7788 - 7795
  • [38] A recombinant allosteric lectin antagonist of HIV-1 envelope gp120 interactions
    McFadden, Karyn
    Cocklin, Simon
    Gopi, Hosahudya
    Baxter, Sabine
    Ajith, Sandya
    Mahmood, Naheed
    Shattock, Robin
    Chaiken, Irwin
    [J]. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2007, 67 (03) : 617 - 629
  • [39] Probing interactions of the HIV protein GP120 with lipids and CD4 receptors
    Donlon, Lynn
    Penaherrera, Ana
    Frankel, Daniel
    [J]. SOFT MATTER, 2013, 9 (10) : 2803 - 2809
  • [40] Mode of action for linear peptide inhibitors of HIV-1 gp120 interactions
    Biorn, AC
    Cocklin, S
    Madani, N
    Si, ZH
    Ivanovic, T
    Samanen, J
    Van Ryk, DI
    Pantophlet, R
    Burton, DR
    Freire, E
    Sodroski, J
    Chaiken, IM
    [J]. BIOCHEMISTRY, 2004, 43 (07) : 1928 - 1938